)
Visual24 Oct 2025
The rise of Alphabet
Pharma Equity Group (PEG) investor relations material
Pharma Equity Group Investor Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor Update summary10 Sep, 2025
Regulatory milestone achieved
Received approval to initiate a pivotal Phase 2 clinical trial for RNX-011 targeting secondary peritonitis, a life-threatening intra-abdominal infection with high mortality.
Approval validates the scientific strategy and marks a key commercial milestone, strengthening the position for future partner negotiations.
Study design and objectives
The trial is randomized, placebo-controlled, and will test a triple-action therapy (fosfomycin, metronidazole, GM-CSF) administered during surgery.
Primary endpoint is reduction in serious postoperative complications, with secondary measures including local inflammation (IL-6) and overall recovery (QoR-15).
Enrollment of 32 patients is planned, with the first patient expected in Q4 2025.
Strategic focus and future outlook
All resources are currently dedicated to advancing Reponex Pharmaceuticals' projects, with a focus on innovative therapies and improving healthcare outcomes.
Long-term strategy includes exploring new investments only after realizing the full potential of current medical projects.
Timeline for securing RNX-011 partnerships?
Justify 32-patient pivotal trial design
Criteria for Reponex's 'full potential'?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Pharma Equity Group earnings date
Q4 202520 Mar, 2026
Next Pharma Equity Group earnings date
Q4 202520 Mar, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Pharma Equity Group A/S is an investment company with a strategic focus on the life sciences sector. It specializes in early-stage investments in life science companies developing technologies and therapies aimed at enhancing human health and quality of life. The company is particularly interested in supporting companies that address significant unmet medical needs. Pharma Equity Group is based in Hørsholm, Denmark, and its shares are listed on the Copenhagen Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage